methylation
Previse Awarded $1.8M NIH Grant to Develop Esophageal Cancer Test
The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.
Lucid Diagnostics Partners With Front Line Mobile to Promote Esophageal Cancer Test
Working with the first responder medical care provider, Lucid is planning high-volume testing events among firefighters and other frontline workers with elevated risk.
Previse Completes Validation Study of Barrett's Esophagus Test, Sees Path to Guideline Inclusion
Premium
The epigenetic risk stratification test demonstrated the potential to decrease surveillance among some patients and increase it among others.
Universal DX Closes Series B Round to Begin Clinical Trial for CRC Screening Test
The firm's blood test uses next-generation sequencing and bioinformatics to identify methylated DNA patterns and fragments from colorectal cancer tumors in the blood.
The company is developing blood-based early detection tests for ovarian and lung cancer that measure tumor-associated proteins on extracellular vesicles.